In the context of lower IL-38 concentrations in patients with the disease, this is a logical hypothesis and was shown effective in e.g., peripheral blood mononuclear cells (PBMCs) from patients with Sjögren’s syndrome (34) and patients with hyperlipidemia (26). Here, IL1F10 is linked to Sjogren syndrome.